Brief: Infinity Pharmaceuticals Posts Q3 Loss Per Share Of $0.12
02/11/2021 20:57
Nov 2 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES COMPANY UPDATE
* Q3 LOSS PER SHARE $0.12
* EXPECTS NET LOSS FOR 2021 TO RANGE FROM $40 MILLION TO $50
MILLION.
* Q3 EARNINGS PER SHARE VIEW $-0.13 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw56nVL3a
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX